{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:43:39Z","timestamp":1789249419743,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejphar.2026.178831","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:21:22Z","timestamp":1774970482000},"page":"178831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Empagliflozin Halts NLRP3 Inflammasome\u2013Mediated Neurodegeneration in Parkinson's Disease in a Rotenone Rat Model"],"prefix":"10.1016","volume":"1021","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2382-0664","authenticated-orcid":false,"given":"Wessam Z.","family":"Ghaith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Wadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"El-Yamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2026.178831_bib1","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1007\/s10753-019-01068-0","article-title":"Potential anti-inflammatory effect of escitalopram in iodoacetamide-induced colitis in depressed ovariectomized rats: Role of \u03b17-nAChR","volume":"42","author":"Abdo","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2026.178831_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174715","article-title":"Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-\u03baB activation in human endothelial cells and differentiated macrophages","volume":"918","author":"Abdollahi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178831_bib3","first-page":"863","article-title":"Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of \u03b1-synuclein and parkin levels in rotenone-induced parkinson's disease in rats","volume":"30","author":"Ahmed","year":"2022","journal-title":"Saudi Pharm. J. : SPJ : Off. Publ. Saudi Pharmaceut. Soc."},{"issue":"6","key":"10.1016\/j.ejphar.2026.178831_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (Nucleotide-Binding domain-like receptor protein 3) inflammasome activation in heart failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circul. Heart fail."},{"key":"10.1016\/j.ejphar.2026.178831_bib49","doi-asserted-by":"crossref","first-page":"1699038","DOI":"10.3389\/fnagi.2026.1699038","article-title":"Research trends on neuroinflammation in Parkinson\u2019s disease: an exploratory analysis","volume":"18","author":"Chen","year":"2026","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2026.178831_bib6","series-title":"Handbook of Histopathological and Histochemical Techniques: including Museum Techniques","author":"Culling","year":"2013"},{"issue":"5","key":"10.1016\/j.ejphar.2026.178831_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.391","article-title":"Inflammasome: structure, biological functions, and therapeutic targets","volume":"4","author":"Dai","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in parkinson's disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178831_bib9","doi-asserted-by":"crossref","first-page":"104765","DOI":"10.1016\/j.jddst.2023.104765","article-title":"Comparative pharmacodynamic study delineating the efficacy of amantadine loaded nano-emulsified organogel via intranasal versus transdermal route in rotenone-induced Parkinson's disease rat model","volume":"86","author":"Farag","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejphar.2026.178831_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113716","article-title":"Crosstalk between SIRT1\/Nrf2 signaling and NLRP3 inflammasome\/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in parkinson's disease","volume":"145","author":"Ghaith","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"465","key":"10.1016\/j.ejphar.2026.178831_bib11","doi-asserted-by":"crossref","first-page":"eaah4066","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.178831_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178831_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1\u03b2 secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178831_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178831_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1601869","article-title":"The phenomenology of parkinson's disease","volume":"37","author":"Hess","year":"2017","journal-title":"Semin. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00607-4","article-title":"Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of alzheimer's disease and type 2 diabetes","volume":"12","author":"Hierro-Bujalance","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.28075","article-title":"Ten unsolved questions about neuroinflammation in parkinson's disease","volume":"36","author":"Hirsch","year":"2021","journal-title":"Mov. Disord.: Off. J. Movem. Disord. Soc."},{"issue":"9","key":"10.1016\/j.ejphar.2026.178831_bib18","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178831_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105014","article-title":"Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of parkinson's disease: the therapeutic role of Nrf2 activators","volume":"145","author":"Jayaram","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2026.178831_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod","volume":"20","author":"Jones","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib21","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178831_bib22","series-title":"Parkinson's Disease: Pathogenesis and Clinical Aspects","article-title":"Parkinson's disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018"},{"issue":"3","key":"10.1016\/j.ejphar.2026.178831_bib23","first-page":"254","article-title":"Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents","volume":"59","author":"Laferriere","year":"2020","journal-title":"JAALAS: JAALAS"},{"key":"10.1016\/j.ejphar.2026.178831_bib24","article-title":"Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2\/Keap1\/SLC7A11 pathway in a microglia cell line","volume":"225","author":"Li","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178831_bib25","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/antiox10121935","article-title":"Two birds one stone: the neuroprotective effect of antidiabetic agents on parkinson disease-focus on sodium-glucose cotransporter 2 (SGLT2) inhibitors","volume":"10","author":"Lin","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.ejphar.2026.178831_bib26","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1080\/21655979.2021.2001240","article-title":"Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3\/caspase-1\/GSDMD pathway in pancreatic \u03b2 cells: in vitro and in vivo studies","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib27","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10787-023-01384-w","article-title":"Empagliflozin repurposing in Parkinson's disease; modulation of oxidative stress, neuroinflammation, AMPK\/SIRT-1\/PGC-1\u03b1, and wnt\/\u03b2-catenin pathways","volume":"32","author":"Mohammed","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2026.178831_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110002","article-title":"Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: targeting the GRP78\/PERK\/eIF2\u03b1\/CHOP pathway and miR-211-5p","volume":"362","author":"Motawi","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.ejphar.2026.178831_bib29","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3233\/JPD-223290","article-title":"Role of NLRP3 inflammasome in Parkinson's disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejphar.2026.178831_bib48","first-page":"401264","article-title":"Oxidative stress and microglial cells in Parkinson\u2019s disease","author":"Peterson","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.178831_bib31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41401-019-0280-2","article-title":"TLR4 deficiency has a protective effect in the MPTP\/probenecid mouse model of Parkinson's disease","volume":"40","author":"Shao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2026.178831_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731483","article-title":"Liraglutide improves cognitive and neuronal function in 3-NP rat model of Huntington's disease","volume":"12","author":"Shawki","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178831_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.114386","article-title":"Rice bran extract mitigates depressive-like behavior in dextran sulfate sodium-induced colitis: involvement of the gut-brain axis and Sirt1 signaling pathway","volume":"184","author":"Shendy","year":"2024","journal-title":"Food Chem. Toxicol.: Int. J. Publ. Brit. Industr. Biol. Res. Assoc."},{"issue":"7575","key":"10.1016\/j.ejphar.2026.178831_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.178831_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109825","article-title":"The SGLT2 inhibitor empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2\/ROS\/NLRP3\/Caspase-1-dependent IL-1\u03b2 and IL-18 secretion","volume":"77","author":"Sukhanov","year":"2021","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.ejphar.2026.178831_bib36","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.178831_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","article-title":"Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in parkinson's disease mouse model","volume":"10","author":"Thi Lai","year":"2024","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejphar.2026.178831_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148536","article-title":"Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy","volume":"1820","author":"\u00dcnal","year":"2023","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.178831_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/biology9050103","article-title":"Clinical features of Parkinson's disease: the evolution of critical symptoms","volume":"9","author":"V\u00e1radi","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2026.178831_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-018-0061-5","article-title":"NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease","volume":"4","author":"von Herrmann","year":"2018","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.ejphar.2026.178831_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122004","article-title":"Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms","volume":"330","author":"Wadie","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178831_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"34","key":"10.1016\/j.ejphar.2026.178831_bib43","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"23","key":"10.1016\/j.ejphar.2026.178831_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314753","article-title":"Pathogenesis of \u03b1-Synuclein in Parkinson's disease: from a neuron-glia crosstalk perspective","volume":"23","author":"Yi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt B","key":"10.1016\/j.ejphar.2026.178831_bib45","article-title":"Recombinant human growth hormone improves the immune status of rats with septic encephalopathy: the role of VEGFR2 in the prevalence of endoplasmic reticulum stress repair module","volume":"101","author":"Zaky","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"18","key":"10.1016\/j.ejphar.2026.178831_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810632","article-title":"NLRP3 inflammasome\/pyroptosis: a key driving force in diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178831_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of parkinson's disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T07:49:04Z","timestamp":1775893744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":49,"alternative-id":["S0014299926003134"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178831","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin Halts NLRP3 Inflammasome\u2013Mediated Neurodegeneration in Parkinson's Disease in a Rotenone Rat Model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178831"}}